Cahill Represents Underwriters in $600 Million Notes Offering for Edwards Lifesciences Corporation
Date: 06/15/18
Cahill represented the underwriters in connection with a public offering of $600,000,000 aggregate principal amount of 4.300% senior notes due 2028 by Edwards Lifesciences Corporation, a medical equipment company specializing in hemodynamic monitoring and artificial heart valves. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.